The present invention relates to a bed, and particularly to patient-care beds. More particularly, the present invention relates to a chair bed that can be manipulated to achieve both a conventional bed position having a horizontal sleeping surface upon which a person lies in a supine position and a sitting position having the feet of the person on or adjacent to the floor and the head and back of the person supported above a seat formed by the bed.
It is known to provide hospital beds having a sleeping surface and siderails. The sleeping surface of such beds can often be manipulated to adjust the position of the person on the sleeping surface. It is also known to provide hospital beds which perform functions such as the prevention/treatment of decubitus ulcers (bedsores), pulmonary rotational therapy, or percussion/vibration therapy.
According to the present disclosure, a support apparatus for supporting a person in a supine position comprises an inflatable support assembly including a rotational therapy device and a pulsation therapy device. The support apparatus also includes a supply of pressurized air, and a control system including a rotation control portion, a pulsation control portion, and a processor in communication with the rotation control portion and in communication with the pulsation control portion. The processor is configured to provide commands to the rotation control portion to control the operation of the rotation control portion and to provide commands to the pulsation control portion to control operation of the pulsation control portion.
The pulsation therapy device may comprise a pulsation bladder configured to selectively receive pressurized air from the source of pressurized air. The pulsation therapy device may be positioned to transmit pulsation therapy to the torso of a person supported on the inflatable support assembly. The controller may cause the pulsation control portion to produce air pulses to the pulsation bladder to provide pulsation therapy.
The inflatable support assembly may further comprise a normally inflated support cushion positioned to support the upper body of a person supported on the inflatable support assembly. The inflatable support assembly may include a lower foam layer and at least a portion of the normally inflated support cushion may be positioned directly above the lower foam layer when the lower foam layer is present. The pulsation therapy device may be supported on the normally inflated support cushion.
The inflatable support assembly may also include a pair of foam members positioned on opposite sides of the head of a person supported on the inflatable support assembly.
The rotation device may comprise a normally inflated bladder configured to support a person on the support apparatus. The controller may cause the rotation control portion to deflate at least a portion of the rotation therapy device to cause a person to be rotated on the support apparatus. The inflatable support assembly may include a normally inflated cushion and the normally inflated cushion may be supported on the rotation therapy device.
The control system may comprise a master processor and the rotation portion may include a slave processor. The pulsation portion may also include a slave processor. The master processor may provide information and commands to each of the slave processors and the slave processors may control hardware associated with the respective rotation therapy device and pulsation therapy device to deliver therapy to a person supported on the support apparatus.
In another aspect of the disclosure a support apparatus including a head end and a foot end comprises a control system, a rotation therapy device, pulsation therapy device, and a dynamic therapy device. The support apparatus also comprises a foam base member supporting the rotation therapy device, and a foam block positioned at the head end of the rotation therapy device.
The control system includes a master processor, a rotation control portion including rotation control logic, a pulsation control portion including rotation control logic, and a dynamic control portion including dynamic control logic. The rotation therapy device is controlled by the rotation control portion of the control system. The pulsation therapy device is controlled by the pulsation control portion of the control system and is supported on the rotation therapy device. The dynamic therapy device is controlled by the dynamic control portion of the control system and is supported on the rotation therapy device.
The rotation therapy device may comprise a normally inflated bladder. Also, the dynamic therapy device may comprise a normally inflated bladder.
The pulsation therapy device may comprise an inflatable bladder configured to be selectively inflated. The pulsation control portion of the control system may be configured to cause air pulses to be transmitted to the bladder to cause pulsation therapy to be delivered to a person supported on the support apparatus.
The master processor may be a node on a network and the rotation control portion, pulsation control portion, and dynamic control portion may not communicate directly with the network.
In some embodiments, during rotation therapy a first bladder of the rotation therapy device inflates and a second bladder deflates.
Additional features of the disclosure will become apparent to those skilled in the art upon consideration of the following detailed description when taken in conjunction with the accompanying drawings.
The detailed description particularly refers to the accompanying figures in which:
A chair bed 10 in accordance with the present disclosure having a head end 12, a foot end 14, and right and left sides 16, 18 is illustrated in
Chair bed 10 includes a bed frame 20 having a base frame 22 and an intermediate frame 24 connected to base frame 22 by lift arms as shown in
Chair bed 10 can be manipulated, either by a caregiver or a person (not shown) on support surface 34, using a hydraulic system so that mattress 32 and articulating deck 26 assume a variety of positions, several of which are shown diagrammatically in
Articulating deck 26 includes a head section 40 having a head portion 41 and a torso portion 43, a seat section 42, a thigh section 44, and a foot section 46. Mattress 32 rests on deck 26 and includes a head portion 48, a torso portion 49, a seat portion 50, a thigh portion 52, and a foot portion 54, each of which generally corresponds to the like-named sections/portions of deck 26, and each of which is generally associated with the head, torso, seat, thighs, and feet of the person on support surface 34. Details of deck 26 and mattress 32 will be explained hereinafter.
Chair bed 10 can assume a bed position having deck 26 configured so that support surface 34 is planar and horizontal, defining an initial position of deck 26 with all sections 40, 42, 44, 46 of deck 26 substantially horizontal as shown in
Chair bed 10 can be moved to a Trendelenburg position shown diagrammatically in
As described above, chair bed 10 is convertible to a chair position shown in
Chair bed 10 is capable of assuming positions in which head, thigh, and foot sections 40, 44, 46 of deck 26 are in positions intermediate to those shown in
Thigh section 44 of articulating deck 26 is movable between a generally horizontal down position and a slightly inclined up position shown diagrammatically in
Foot section 46 of articulating deck 26 is movable from a generally horizontal up position parallel to intermediate frame 24, as shown in
As foot section 46 pivots from the up position to the down position, inflatable foot portion 54 of mattress 32 deflates, as shown in
Additionally, articulating deck 26 of chair bed 10 is configured as a step deck as shown in
Mattress 32 includes generally upwardly-facing support surface 34 and a bottom surface 78 that is generally parallel to support surface 34 and positioned beneath support surface 34. A perimeter side 80 connects support surface 34 and bottom surface 78. Additional disclosure of mattress 32 is discussed below.
Siderails 28, 30 are passive restraint devices mounted on both sides of chair bed 10 as shown in
Head end siderails 28 are mounted to head section 40 of articulating deck 26, and foot end siderails 30 are mounted to move or stay with seat section 42 of deck 26. Head end siderails 28 move with head section 40 of deck 26 as head section 40 pivots between the down position and the back-support position. Foot end siderails 30 are generally fixed in an angular orientation relative to intermediate frame 24. Additional description of siderails 28, 30 is provided in U.S. Pat. No. 5,715,548.
Mattress 32 is configured to provide support and treatment to a patient while also permitting articulating deck 26 to move to the chair position. Mattress 32 includes several inflatable treatment apparatus for providing several types of therapy. Mattress 32 includes a rotational therapy device 110 for providing pulmonary rotational therapy, a pulsation therapy device 112 for providing percussion and/or vibration therapy, and a treatment device 114 for providing decubitus ulcer (bedsore) treatment and prevention.
Mattress 32 includes a cover 116 defining support surface 34, perimeter side 80, and bottom surface 78. Head portion 48 of mattress 32 is positioned over head portion 41 of head section 40 of deck 26. Head portion 48 includes a lower foam layer 118 positioned on top of a bottom surface of cover 116. Head portion 48 further includes a first intermediate foam layer 122 positioned on top of lower foam layer 118. A multi-component second intermediate foam layer 124 is positioned on top of first intermediate foam layer 122 and includes first, second, and third portions 126, 128, 130 as shown in
Head portion 48 further includes an inflatable head bladder 132 positioned on top of second portion 128 of second intermediate foam layer 124. Head bladder 132 includes air tubes 180 positioned adjacent cover 116. Head portion 48 further includes first and second foam blocks 134, 136 positioned on opposite sides of inflatable head bladder 132. Head portion 48 further includes a pair of vertically oriented foam blocks 137 positioned on opposite sides of first and second intermediate foam layers 122, 124 and first and second foam blocks 134, 136 as shown in
Foam blocks 137 are made of a more rigid foam material to provide a “fence” configured to direct a patient's head away from the sides of head portion 48. Foam layer 118 is made of a stiffer material than first intermediate foam layer 122. First and third portions 126, 130 of second intermediate foam layer 124 are made of a less stiff material than first intermediate foam layer 127 and second portion 128 is made of a less stiff material than first and third portions 126, 130. First and second foam blocks 134, 136 are made of a stiff material that is less stiff than second portion 128. Thus, head portion 48 of mattress 34 is provided with a stiffness gradient. According to an alternative embodiment, the foam components are made of other resilient materials.
An alternative embodiment head portion 310 for use with a mattress is shown in
Head portion 310 includes an inflatable head bladder 326 positioned on top foam layer 324. Head portion 310 further includes a pair of vertically oriented foam blocks 328 positioned on opposite sides of first and second intermediate foam layers 314, 316 and top foam layer 324 and a vertically oriented foam panel 330 positioned on a head end of first and second intermediate foam layers 314, 316 and top foam layer 324.
Foam blocks 328 and foam panel 330 are made of a more rigid foam material to provide a “fence” configured to direct a patient's head away from the sides of head portion 310. Lower foam layer 312 is made of a stiffer material than first intermediate foam layer 314. First and third portions 318, 322 of second intermediate foam layer 316 are made of a less stiff material than first intermediate foam layer 314 and second portion 320 is made of a less stiff material than first and third portions 318, 322. Top foam layer 324 is made of material that is less stiff than second portion 320.
Torso, seat, and thigh portions 49, 50, 52 of mattress 32 share several components. For example, torso, seat, and thigh portions 49, 50, 52 includes a two component foam panel 138 positioned on top of cover 116. Foam panel 138 is sized to substantially fill in recess 68 of deck 26 as shown in FIGS. 12 and 17-22. Foam panel 138 includes a recess 139 that houses conduits (not shown) which couple to the various inflatable bladders. Torso, seat, and thigh portions 49, 50, 52 also share inflatable bolsters 140 positioned over side portions 72 of deck 26 as shown in
Torso, seat, and thigh portions 49, 50, 52 also share first and second top foam layers 142, 144. These foam layers 142, 144 are positioned adjacent support surface 34 of cover 116, terminate short of head and foot portions 48, 54 of mattress 32, and extend over side portions 72 of deck 26. First layer foam layer 142 is made of a less stiff material than second foam layer 144.
Torso portion 49 of mattress 32 also includes several components of the various inflatable treatment apparatus. Mattress 32 includes a treatment bladder 149 and right and left working bladders 145, 147 positioned over torso portion 43 of head section 40 and seat and thigh sections 42, 44 of deck 26 as shown in
Treatment bladder 149 is divided into first, second, and third treatment zones 154, 165, 175 that are independently inflated and deflated as will be discussed in greater detail below. Right and left boost bladders 151, 153 each include respective first and second bladder sections 146, 156, 148, 158. Mattress 32 further includes right and left boost bladders 166, 168 positioned in foot portion 54 of mattress 32 that are in fluid communication with respective right and left boost bladders 151, 153.
Torso portion 49 includes first sections 146, 148 of right and left boost bladders 151, 153 positioned on right and left sides of mattress 34 that are deflated during normal operation of bed 10. Torso portion 49 further includes portions of right and left working bladders 145147 positioned under second foam layer 144 and over boost bladders 146, 148 on right and left sides of mattress 34 that are inflated during normal operation of bed 10. Torso portion 49 also includes first treatment zone 154 of treatment bladder 149 positioned over each working bladder 145, 147. Torso portion 49 further includes a pulsation bladder 155 positioned between cover 116 and first foam layer 142.
As shown in
Similar to seat portion 50, thigh portion 52 of mattress 32 also includes several components of the various inflatable treatment apparatus. As shown in
As shown in
Mattress 32 further includes a foam panel 174 providing a resilient component positioned between thigh and foot portions 52, 54 of mattress 32. Panel 174 substantially fills a gap that widens between thigh and foot portions 52, 54 when foot section 46 of deck 26 is lowered. Panel 174 is preferably positioned between second boost bladder sections 156, 158 and boost bladders 166, 168.
Bed 10 includes a peer-to-peer network 276 and several control modules which control the inflation and deflation of the bladders are coupled to the network 276, as shown in
According to the presently preferred embodiment of the disclosure, a pulmonary pulsation control module 177, a pulmonary rotation control module 188, a normal operation control module 190, and a treatment therapy control module 113 are electrically coupled to foot section control module 220 and receive commands from peer-to-peer network 276 through foot section control module 220. Thus, a master-slave relationship exists between foot section control module 220 and pulmonary pulsation control module 177, pulmonary rotation control module 188, normal operation control module 190, and treatment therapy control module 113.
Inflatable head bladder 132, treatment bladder 149, foot bladder 170, and right and left working bladders 145, 147 are inflated during normal operation of bed 10 by treatment therapy and normal operation control modules 113, 190 as shown in
Pulsation therapy device 112 is configured to provide vibration and/or percussion therapy to a patient. Pulsation therapy device 112 includes pulmonary pulsation control module 177 that provides predetermined pulsations of air to pulsation bladder 155 to quickly oscillate the pressure levels in pulsation bladder 155. Pulmonary pulsation control module 177 is coupled to pulsation bladder 155 by air conduits (not shown).
Pulsation bladder 155 includes three aligned air tubes 178 positioned between cover 116 and first and second foam layers 142, 144. Tubes 178 are oriented transverse to a longitudinal axis of bed 10. Each air tube 178 is in fluid communication with the other air tubes 178. According to alternative embodiments of the present disclosure, the pulsation bladder includes fewer or more tubes of alternative configurations.
To perform pulsation therapy, pulmonary pulsation control module 177 is coupled to bed 10 and air tubes 178 of pulsation bladder 155 are inflated as shown, for example, in
Treatment device 114 is configured to provide prevention and/or treatment of decubitus ulcers (bedsores). Treatment device 114 includes treatment therapy control module 113 having a set of valves that coordinates inflation and deflation of first, second, and third treatment zones 154, 165, 175 of treatment bladder 149 so that these longitudinally positioned treatment zones 154, 165, 175 oscillate between inflated and deflated positions to cause support surface 34 to undulate. Treatment therapy control module 113 is coupled to respective treatment zones 154, 165, 175 by air conduits. Preferred treatment therapy control module 113 is described in greater detail below.
Each treatment zone 154, 165, 175 includes a plurality of aligned air tubes 182, 184, 185. Air tubes 182, 184, 185 of first, second, and third treatment zones 154, 165, 175 are positioned between first and second foam layers 142, 144 and right and left working bladders 145, 147 as shown, for example, in
To perform decubitus ulcer (bedsore) treatment, treatment therapy control module 113 is coupled to bed 10 so that treatment zones 154, 165, 175 are inflated and deflated to raise and lower different portions of the patient's body at different times and/or intervals. According to the presently preferred embodiment, the coordination of the oscillations creates a wave pattern as first, second, and third treatment zones 154, 165, 175 are sequentially inflated and deflated. The deflation and inflation of each treatment bladder may begin before, during, or after inflation/deflation of the proceeding treatment bladder. According to alternative embodiments, other patters of inflation and deflation of the treatment bladders is provided.
When treatment is complete, treatment therapy control module 113 is removed from bed 10. Thus, treatment device 114 provides an inflatable treatment apparatus configured to move between inflated and deflated positions to provide decubitus ulcer (bedsore) treatment and/or prevention to a patient positioned on support surface 34.
Pulmonary rotation therapy device 110 is configured to perform rotational therapy on a patient. Pulmonary rotation therapy device 110 includes pulmonary rotation control module 188 having a set of valves and right and left working bladders 145, 147, and companion right and left boost bladders 151, 153, 166, 168 positioned under and snapped to the respective right and left working bladders 145, 147. Pulmonary rotation control module 188 is coupled to respective boost bladders 151, 153, 166, 168 by air conduits (not shown) to control oscillations between the inflated and deflated positions. Normal operation control module 190 is coupled to right and left working bladders 145, 147 by conduits (not shown) and receives commands from pulmonary rotation control module 188 to coordinate inflation and deflation of right and left working bladders 145, 147 with inflation and deflation of respective boost bladders 151, 153, 166, 168.
Right working and boost bladders 145, 151, 166 positioned on the right side of mattress 32 cooperate to raise and lower the right portion of support surface 34. Similarly, left working and boost bladders 147, 153, 168 positioned on the left side of support surface 34 cooperate to raise and lower the left portion of support surface 34.
As previously mentioned, boost bladders 151, 153, 166, 168 are in a deflated position within mattress 32 until it is desired to treat the patient with rotational therapy, but right and left working bladders 145, 147 are normally inflated, as shown in
When it is desired to provide rotational treatment to the patient, pulmonary rotation control module 188 is moved to an attached position coupled to bed 10 to begin the rotational therapy operation. A graphical interactive display (not shown) of bed 10 or a graphic caregiver interface module (not shown) automatically recognizes that pulmonary rotation control module 188 is attached to bed 10. Therefore, controls for pulmonary rotation therapy device 110 can be actuated from the graphical interactive display or the graphic caregiver interface. Normal operation control module 190 is permanently coupled to bed 10 and maintains right and left working bladders 145, 147 in the inflated position during normal operation of bed 10.
The combination of inflation and deflation raises the left portion of support surface 34 to a raised height 196 that is greater than normal height 176 and lowers the right portion of support surface 34 to a lowered height 198 that is less than normal height 176. Between the first and second phases of the rotational therapy operation, pulmonary rotation control module 188 and normal operation control module 190 inflate and deflate the respective bladders to the next respective position. During rotational therapy, head bladder 132 is slightly deflated to “cradle” the patient's head as shown in
To end the rotational therapy operation, pulmonary rotation control module 188 is removed from bed 10 to a detached position so that boost bladders 151, 153, 166, 168 return to the deflated state (if not already deflated). Normal operation control module 190 returns working bladders 145, 147 to the inflated position as shown in
As shown, for example, in
Foot portion 54 of mattress 32 is particularly designed for use with chair bed 10 of the present disclosure that has retractable foot section 46 of deck 26. An alternative embodiment of foot portion 410 of mattress 32 is shown in
This orientation of tubes 216, 218 in foot portion 54 of mattress 32 causes foot portion 54 to retract or shorten and to collapse or thin as tubes 216 are deflated by a foot section control module 220 as hospital bed 10 moves from the bed position to the chair position. In the chair position, foot section 46 of deck 26 and foot portion 54 of mattress 32 move from a generally horizontal position to a generally vertical, downwardly extending position. Preferably, foot section 46 moves from an extended position to a retracted position to shorten foot section 46 as articulating deck 26 of bed 10 moves to the chair configuration.
Heel tube 217 is configured to reduce the pressure on the heel of the patient. Because foot section 46 is retractable, heel tube 217 can be positioned under the heels of the patient by retracting foot section 46 until the patient's heels are positioned over heel tube 217. Foot section control module 220 includes a pressure transducer that monitors the pressure in heel tube 217. If the pressure exceeds a predetermined value, the pressure in heel tube 217 is reduced to avoid decubitus ulcers (bedsores) on the patient's heels.
As shown in
Air tubes 416, 418 are configured to collapse to a near zero dimension when air is withdrawn from tubes 416, 418.
The orientation of tubes 416, 418 in foot portion 410 causes foot portion 410 to retract or shorten and to collapse or thin as tubes 416 are deflated by a foot section control module as the hospital bed 10 moves from the bed position to the chair position. In the chair position, the foot section of the deck and foot portion 410 of the mattress move from a generally horizontal position to a generally vertical, downwardly extending position. Preferably, foot section 410 moves from an extended position to a retracted position to shorten the foot section as the articulating deck of the 10 moves to the chair configuration. Additional description of the foot section of the articulating deck and the tubes of the foot portion of the mattress is provided in U.S. Pat. No. 5,715,548.
A preferred embodiment control module configuration is shown in
As shown in
Each control module 113, 177, 188, 190, 220 includes a slave processor 310, a ROM circuit 312 coupled to the respective slave processors 310, an analog-to-digital converter 314 coupled to the respective slave processors 310, and pressure transducers 316 coupled to the respective analog-to-digital converters 314. Slave processor 310 of foot section control module 220 is directly coupled to master processor 286 to communicate therewith and slave processors 310 of slave modules 113, 177, 188, 190 are coupled to connectors 318 to communicate with master processor 286 through master/slave communication network 280.
Master processor 286 is a centralized hub between peer-to-peer network 276 and slave modules 113, 177, 188, 190. Master processor 286 receives information/commands from peer-to-peer network 276 and distributes the appropriate information/commands to the respective slave processor 310 of each slave module 113, 177, 188, 190, through master/slave communication network 280. Similarly, master processor 286 receives information/commands from the respective slave processors 310 of each slave module 113, 177, 188, 190. Slave processor 310 of foot section control module 220 sends and receives information/commands directly to and from master processor 286.
As shown in
Pressure transducer 316 monitors the air pressure in heel tube 217 so that the air pressure in heel tube 217 does not exceed a predetermined level. If pressure transducer 316 senses a pressure over the predetermined level, slave processor 310 of foot section control module 220 commands stepper motor drivers 336 to open vacuum valve 320 so that the pressure is lowered below the predetermined level. If pressure transducer 316 senses a pressure level below a predetermined level, slave processor 310 of foot section control module 220 commands stepper motor drivers 336 to open pressure valve 326 so that the pressure is raised above the predetermined level.
When slave processor 310 of foot section control module 220 receives a command to retract foot bladder 170 from peer-to-peer network 276 through master processor 286, slave processor 310 commands stepper drivers 336 to move vacuum valve 322 to the opened position so that air is drawn from first set of tubes 216 into vacuum inlet 332 of blower 332 so that air tubes 216 deflate to retract foot bladder 170. When slave processor 310 of foot section control module 220 receives a command to extend foot bladder 170, slave processor 310 commands stepper drivers 336 to close vacuum valve 322 and move pressure valve 328 to the opened position so that air enters first set of tubes 216 from pressure outlet 334 of blower 298 so that air tubes 216 inflate to extend foot bladder 170. Pressure transducer 316 monitors the pressure levels in first set of tubes 216 during retraction, expansion, and normal operation to determine when first set of tubes 216 are with predetermined pressure ranges.
When slave processor 310 of foot section control module 220 receives a command to collapse foot bladder 170, slave processor 310 commands stepper drivers 336 to move vacuum valves 322, 324 to the opened position so that air is drawn from first and second sets of tubes 216, 218 into vacuum inlet 332 of blower 332 so that air tubes 216, 218 deflate to collapse a portion of foot bladder 170. When slave processor 310 of foot section control module 220 receives a command to expand foot bladder 170, slave processor 310 commands stepper drivers 336 to close vacuum valves 322, 324 and move pressure valves 328, 330 to the opened position so that air enters first and second sets of tubes 216, 218 from pressure outlet 334 of blower 298 so that air tubes 216, 218 inflate to expand foot bladder 170. Pressure transducer 316 monitors the pressure levels in first and second sets of tubes 216, 218 during collapsing, expansion, and normal operation to determine when first and second sets of tubes 216, 218 are with predetermined pressure ranges.
As shown in
When slave processor 310 of pulmonary pulsation control module 177 receives a command to begin pulmonary pulsation therapy from peer-to-peer network 276 through master processor 286, slave processor 310 commands solenoid valve driver 340 to begin operation of pulsation valve 338 so that oscillations of pressurized air are sent to pulsation bladder 155. When slave processor 310 of pulmonary pulsation control module 177 receives a command to stop pulmonary pulsation therapy, slave processor 310 commands solenoid valve driver 340 to discontinue operation of pulsation valve 338. Pressure transducer 316 of pulmonary pulsation control module 177 monitors the pressure levels in pulsation bladder 155 during pulsation therapy to determine when the pressure level of pulsation bladder 155 is within an acceptable predetermined pressure range.
As shown in
During normal operation, pressure transducer 316 monitors the pressure level in head bladder 132. When the pressure in head bladder 132 drops below a predetermined level, pressure valve 350 is moved to the opened position until the pressure increases above a predetermined level. When the pressure in head bladder 132 rises above a predetermined level, vacuum valve 344 opens until the pressure decreases below a predetermined level. As previously mentioned, during rotational therapy, head bladder 132 is slightly deflated by vacuum valve 344 to “cradle” the patient's head as shown in
Similarly, during normal operation, pressure transducer 316 monitors the pressure level in right and left working bladders 145, 147. When the pressures in right and left working bladders 145, 147 drop below a predetermined level, respective pressure valves 352, 354 are moved to the opened position until the pressures increase above a predetermined level. When the pressures in respective right and left working bladders 145, 147 rise above a predetermined level, respective vacuum valve 346, 348 open until the pressures increase below a predetermined level.
As shown in
When slave processor 310 of pulmonary rotational control module 188 receives a command to begin pulmonary rotational therapy from peer-to-peer network 276 through master processor 286, slave processor 310 commands stepper motor drivers 364 to move vacuum valve 356 to the opened position, vacuum valve 358 to the closed position, pressure valve 360 to the closed position, and pressure valve 362 to the opened position so that air is drawn from left boost bladders 153, 168 and air is introduced to right boost bladders 151, 166 as shown in
The communication from slave processor 310 of pulmonary rotational control module 188 to slave processor 310 of normal operation control module 190 occurs through master processor 286 and master/slave communication network 280. During inflation of right boost bladders 151, 166, right working bladder 145 is inflated when stepper motor drivers 336 move pressure valve 352 to the opened position as shown in
To begin the second phase of pulmonary rotational therapy, slave processor 310 commands stepper drivers 364 to move vacuum valve 358 to the opened position, vacuum valve 356 to the closed position, pressure valve 362 to the closed position, and pressure valve 360 to the opened position so that air is drawn from right boost bladders 151, 166 and air is introduced to left boost bladders 153, 168 as shown in
During inflation of left boost bladders 153, 168, left working bladder 145 is inflated when stepper motor drivers 336 move pressure valve 354 to the opened position as shown in
When slave processor 310 of pulmonary rotational control module 188 receives a command to end pulmonary rotational therapy, slave processor 310 commands stepper drivers 364 to move vacuum valves 356, 358 to the opened position so that air is drawn from right and left boost bladders 151, 153, 166, 168 as shown in
As shown in
During a first phase of treatment therapy, first treatment zone 154 is deflated and the other treatment zones 165, 175 remain inflated. To begin the first phase of treatment therapy, slave processor 310 of treatment therapy control module 113 sends commands to stepper motor drivers 378 to move vacuum valve 370 to the opened position and pressure valve 376 to the closed position so that air is drawn from first treatment zone 154 of treatment bladder 149. To end the first phase of treatment therapy, slave processor 310 of treatment therapy control module 113 commands stepper motor drivers 378 to move vacuum valve 370 to the closed position and pressure valve 376 to the opened position so that first treatment zone 154 of treatment bladder 149 moves to the inflated position.
During a second phase of treatment therapy, second treatment bladder 165 is deflated and the other treatment zones 154, 175 remain inflated. To begin the second phase of treatment therapy, slave processor 310 of treatment therapy control module 113 sends commands to stepper motor drivers 378 to move vacuum valve 368 to the opened position and pressure valve 374 to the closed position so that air is drawn from second treatment zone 165. To end the second phase of treatment therapy, slave processor 310 of treatment therapy control module 113 commands stepper motor drivers 378 to move vacuum valve 368 to the closed position and pressure valve 374 to the opened position so that second treatment zone 165 moves to the inflated position.
During a third phase of treatment therapy, third treatment zone 175 is deflated and the other treatment zones 154, 165 remain inflated. To begin the third phase of treatment therapy, slave processor 310 of treatment therapy control module 113 sends commands to stepper motor drivers 378 to move vacuum valve 366 to the opened position and pressure valve 372 to the closed position so that air is drawn from third treatment zone 175. To end the third phase of treatment therapy, slave processor 310 of treatment therapy control module 113 commands stepper motor drivers 378 to move vacuum valve 366 to the closed position and pressure valve 372 to the opened position so that third treatment zone 175 moves to the inflated position.
According to the presently preferred embodiment, the first, second, and third phases of treatment therapy are sequential. According to alternative embodiments, other patterns of inflation and deflation of the treatment bladders are followed. According to other alternative embodiments, the head and foot bladders are also inflated and deflated as part of treatment therapy.
Bed 10 is configured to disable any therapy when bed 10 is in the chair position. Bed 10 includes a sensor 230, as shown in
Sensor 230 is coupled to communicate with the respective control modules of the inflatable therapy apparatus 110, 112, 114. When sensor 230 detects that foot section 46 of deck 26 drops below a predetermined displacement angle, sensor 230 instructs the respective control modules to terminate therapy.
Bed 10 is also configured to disable any therapy when any of siderails 28, are lowered from the raised position. Bed 10 includes four sets of siderail sensors or position detectors 232, as shown in
Each siderail sensor 232 includes a proximity clip 238 coupled to a proximal end of link 236, as shown in
As link 236 of respective siderail 28, 30 rotates from the up position to the down position, magnet 244 moves relative to switch 240 from a first position (shown in solid lines in
Switch 240 is in communication with the respective control modules of the inflatable therapy apparatus 110, 112, 114. When switch 240 detects that any of siderails 28, 30 drop below a predetermined level, switch 240 instructs the respective control modules to terminate therapy.
An alternative embodiment siderail sensor 252 is shown in
As siderail component 256 moves during rotation of the respective siderail from the up position to the down position, magnet 266 moves relative to switch 274 from a first position relative to switch 274 to a second position further away from switch 274. Switch 274 is configured to detect the change in position of magnet 266 so that as magnet 266 moves toward the second position, switch 274 detects the change in position of the respective siderail.
Switch 274 is in communication with the respective control modules of the inflatable therapy apparatus. When switch 274 detects that any of the siderails drop below a predetermined level, switch 274 instructs the respective control modules to terminate therapy.
Although the invention has been described in detail with reference to preferred embodiments, variations and modifications exist within the scope and spirit of the invention as described and defined in the following claims.
This application is a continuation of U.S. patent application Ser. No. 11/487,630, filed Jul. 17, 2006, now U.S. Pat. No. 7,451,506, which is a continuation of U.S. patent application Ser. No. 10/611,094, filed Jul. 1, 2003, now U.S. Pat. No. 7,076,818, which is a continuation of U.S. patent application Ser. No. 09/532,592, filed Mar. 22, 2000, now U.S. Pat. No. 6,584,628, which is a continuation-in-part of application U.S. patent application Ser. No. 09/018,542, filed Feb. 4, 1998, now U.S. Pat. No. 6,163,903, which is a continuation of U.S. patent application Ser. No. 08/511,711, filed Aug. 4, 1995, now U.S. Pat. No. 5,715,548, the disclosures of which are all expressly incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
585834 | Ruth | Jul 1897 | A |
598054 | Any | Jan 1898 | A |
1398203 | Schmidt | Nov 1921 | A |
1772310 | Hart | Aug 1930 | A |
2308592 | Drexler | Jan 1943 | A |
2452366 | Freund | Oct 1948 | A |
2644173 | James | Jul 1953 | A |
2734104 | Gollhofer | Feb 1956 | A |
3038174 | Donovan | Jun 1962 | A |
3108492 | Johnson | Oct 1963 | A |
3210779 | Herbold | Oct 1965 | A |
3220022 | Ted | Nov 1965 | A |
3231904 | Irving | Feb 1966 | A |
3321779 | Tabler | May 1967 | A |
3406772 | Adolf | Oct 1968 | A |
3593350 | Knight | Jul 1971 | A |
3674019 | Grant | Jul 1972 | A |
3724003 | Ellwanger et al. | Apr 1973 | A |
3742530 | Clark | Jul 1973 | A |
3818414 | Davies | Jun 1974 | A |
3867732 | Morrell et al. | Feb 1975 | A |
3877090 | Schutz et al. | Apr 1975 | A |
3913153 | Adams et al. | Oct 1975 | A |
4038709 | Kerwit | Aug 1977 | A |
4127906 | Zur | Dec 1978 | A |
4183015 | Drew et al. | Jan 1980 | A |
4183109 | Howell | Jan 1980 | A |
4193149 | Welch | Mar 1980 | A |
4224706 | Young et al. | Sep 1980 | A |
4231030 | Weiss | Oct 1980 | A |
4232415 | Webber | Nov 1980 | A |
4258445 | Zur | Mar 1981 | A |
4394784 | Swenson et al. | Jul 1983 | A |
4409695 | Johnston et al. | Oct 1983 | A |
4411035 | Fenwick | Oct 1983 | A |
4435862 | King | Mar 1984 | A |
4435864 | Callaway | Mar 1984 | A |
4477935 | Griffin | Oct 1984 | A |
4525409 | Elesh | Jun 1985 | A |
4525885 | Hunt et al. | Jul 1985 | A |
4527298 | Moulton | Jul 1985 | A |
4534077 | Martin | Aug 1985 | A |
4628556 | Blackman | Dec 1986 | A |
4628557 | Murphy | Dec 1986 | A |
4638313 | Sherwood et al. | Jan 1987 | A |
4638519 | Hess | Jan 1987 | A |
4669136 | Waters et al. | Jun 1987 | A |
4670923 | Gabriel | Jun 1987 | A |
4680790 | Packard et al. | Jul 1987 | A |
4787104 | Grantham | Nov 1988 | A |
4800384 | Snijders | Jan 1989 | A |
4803744 | Peck et al. | Feb 1989 | A |
4825486 | Kimura et al. | May 1989 | A |
4862529 | Peck | Sep 1989 | A |
4873734 | Pollard | Oct 1989 | A |
4897890 | Walker | Feb 1990 | A |
4912787 | Bradcovich | Apr 1990 | A |
4914760 | Hargest et al. | Apr 1990 | A |
4926457 | Poehner et al. | May 1990 | A |
4944055 | Shainfeld | Jul 1990 | A |
4951335 | Eady | Aug 1990 | A |
4977633 | Chaffee | Dec 1990 | A |
4982466 | Higgins et al. | Jan 1991 | A |
4986738 | Kawasaki | Jan 1991 | A |
4987620 | Sharon | Jan 1991 | A |
4987623 | Stryker et al. | Jan 1991 | A |
4991244 | Walker | Feb 1991 | A |
4993920 | Harkleroad | Feb 1991 | A |
4998939 | Potthast et al. | Mar 1991 | A |
4999867 | Toivio | Mar 1991 | A |
5007123 | Salyards | Apr 1991 | A |
5018786 | Goldstein | May 1991 | A |
5023967 | Ferrand | Jun 1991 | A |
5029352 | Hargest et al. | Jul 1991 | A |
5035014 | Blanchard | Jul 1991 | A |
5044025 | Hunsinger et al. | Sep 1991 | A |
5044364 | Crowther | Sep 1991 | A |
5052068 | Graebe | Oct 1991 | A |
5060174 | Gross | Oct 1991 | A |
5062169 | Kennedy et al. | Nov 1991 | A |
5065464 | Blanchard | Nov 1991 | A |
5068933 | Sexton | Dec 1991 | A |
5072463 | Willis | Dec 1991 | A |
5077843 | Foster | Jan 1992 | A |
5083332 | Foster et al. | Jan 1992 | A |
5083335 | Krouskop | Jan 1992 | A |
5095561 | Green | Mar 1992 | A |
5095568 | Thomas et al. | Mar 1992 | A |
5103519 | Hasty | Apr 1992 | A |
5121512 | Kaufmann | Jun 1992 | A |
5121756 | Koledin | Jun 1992 | A |
5129117 | Celestina et al. | Jul 1992 | A |
5142719 | Vrzalik | Sep 1992 | A |
5148562 | Borders et al. | Sep 1992 | A |
5152021 | Vrzalik | Oct 1992 | A |
5157787 | Donnellan et al. | Oct 1992 | A |
5157800 | Borders | Oct 1992 | A |
5168589 | Stroh et al. | Dec 1992 | A |
5170364 | Gross et al. | Dec 1992 | A |
5179742 | Oberle | Jan 1993 | A |
5179744 | Foster et al. | Jan 1993 | A |
5181288 | Heaton et al. | Jan 1993 | A |
5191663 | Holder et al. | Mar 1993 | A |
5235258 | Schuerch | Aug 1993 | A |
5274311 | Littlejohn | Dec 1993 | A |
5276813 | Elliott et al. | Jan 1994 | A |
5279010 | Ferrand et al. | Jan 1994 | A |
5283781 | Buda et al. | Feb 1994 | A |
5291399 | Chaco | Mar 1994 | A |
5317769 | Weismiller et al. | Jun 1994 | A |
5325551 | Tappel et al. | Jul 1994 | A |
5331698 | Newkirk et al. | Jul 1994 | A |
5335384 | Foster | Aug 1994 | A |
5361755 | Schraag | Nov 1994 | A |
5367728 | Chang | Nov 1994 | A |
5373595 | Johnson et al. | Dec 1994 | A |
5375273 | Bodine | Dec 1994 | A |
5377370 | Foster | Jan 1995 | A |
5394580 | Foster et al. | Mar 1995 | A |
5398357 | Foster | Mar 1995 | A |
5421046 | Vande Streek | Jun 1995 | A |
5450641 | Montgomery | Sep 1995 | A |
5454126 | Foster et al. | Oct 1995 | A |
5479666 | Foster et al. | Jan 1996 | A |
5481772 | Glynn et al. | Jan 1996 | A |
5483709 | Foster | Jan 1996 | A |
5487196 | Wilkinson | Jan 1996 | A |
5522100 | Schilling et al. | Jun 1996 | A |
5539943 | Romano | Jul 1996 | A |
5542136 | Tappel | Aug 1996 | A |
5542138 | Williams | Aug 1996 | A |
5564142 | Liu | Oct 1996 | A |
5577279 | Foster et al. | Nov 1996 | A |
5586346 | Stacy et al. | Dec 1996 | A |
5592945 | Fiedler | Jan 1997 | A |
5606754 | Hand et al. | Mar 1997 | A |
5611096 | Bartlett et al. | Mar 1997 | A |
5630238 | Weismiller et al. | May 1997 | A |
5664270 | Bell et al. | Sep 1997 | A |
5666681 | Meyer et al. | Sep 1997 | A |
5689229 | Chaco et al. | Nov 1997 | A |
5699038 | Ulrich et al. | Dec 1997 | A |
5715548 | Weismiller et al. | Feb 1998 | A |
5771511 | Kummer et al. | Jun 1998 | A |
5781949 | Weismiller et al. | Jul 1998 | A |
5787528 | Antinori | Aug 1998 | A |
5802640 | Ferrand et al. | Sep 1998 | A |
5904172 | Gifft et al. | May 1999 | A |
5983429 | Stacy et al. | Nov 1999 | A |
6021533 | Ellis et al. | Feb 2000 | A |
6047424 | Osborne et al. | Apr 2000 | A |
6079070 | Flick | Jun 2000 | A |
6085372 | James | Jul 2000 | A |
6119291 | Osborne et al. | Sep 2000 | A |
6145142 | Rechin | Nov 2000 | A |
6163903 | Weismiller et al. | Dec 2000 | A |
6279183 | Kummer et al. | Aug 2001 | B1 |
6584628 | Kummer et al. | Jul 2003 | B1 |
6668408 | Ferrand et al. | Dec 2003 | B2 |
7076818 | Kummer et al. | Jul 2006 | B2 |
20040034931 | Kummer et al. | Feb 2004 | A1 |
Number | Date | Country |
---|---|---|
2199803 | Jul 1988 | GB |
9409686 | May 1994 | WO |
9427544 | May 1994 | WO |
9909865 | Aug 1997 | WO |
Number | Date | Country | |
---|---|---|---|
20090064416 A1 | Mar 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11487630 | Jul 2006 | US |
Child | 12272505 | US | |
Parent | 10611094 | Jul 2003 | US |
Child | 11487630 | US | |
Parent | 09532592 | Mar 2000 | US |
Child | 10611094 | US | |
Parent | 08511711 | Aug 1995 | US |
Child | 09018542 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09018542 | Feb 1998 | US |
Child | 09532592 | US |